News & Events
A new prototype of a drug for lateral sclerosis
- February 29, 2020
- Posted by: Wiley M. Wagner
- Category: Science
ALS – diagnosis written on a white piece of paper. Syringe and vaccine with drugs.
Diseases of motor neurons like amyotrophic lateral sclerosis are really dangerous diseases that take the lives of many patients for literally a couple of years. There are many test drugs and compounds designed to help fight the so-called amyloid dice that accumulate in the affected brain cells, which cause symptoms – however, they are quite ambiguous mechanisms. However, today Australian experts in the field of neurobiology presented their development of a drug called CuATSM, designed to deal with this symptom.
In fact, this drug compound has existed for more than 15 years and all this time it was tested by specialists in various conditions and tests – having demonstrated positive results on animal subjects, at the end of 2016 the drug began to be tested on some human patients, showing no less interesting results. The fact is that the new medicine is based on the theory that the formation of amyloid dice causing neural degradation occurs due to an insufficient amount of copper in neural compounds and brain cells – although the original theory sounded exactly the opposite.
After conducting a series of studies on their medicine and copper itself, experts found that the more copper injects copper into needy brain cells, the faster the symptoms of neural degradation dissipate and the course of the disease slows down noticeably. These results were obtained on the basis of tests on 32 patients, two of whom were able to achieve partial remission using only CuATSM.
Such a result is really promising and, on the whole, represents a really excellent step towards an even more confident and reliable way of combating various neurodegenerative diseases. Be that as it may, neuroscientists from Australia are already preparing to move on to the second stage of testing their medicine.